INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Lawsuit Involving Chiasma, Inc. and a Lead Plaintiff Deadline of August 8, 2016
NEW YORK, July 11, 2016 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Massachusetts on behalf of investors who purchased Chiasma, Inc. (NASDAQ:CHMA) securities between July 15, 2015 and April 17, 2016.
Click here to learn about the case: http://www.wongesq.com/pslra/chiasma. There is no cost or obligation to you.
According to the complaint, among other allegations, defendants made false and/or misleading statements and/or failed to disclose that (i) Chiasma’s Phase 3 clinical trial methodology for Mycapssa was not sufficient to demonstrate efficacy and secure approval by the U.S. Food and Drug Administration (“FDA”); (ii) Chiasma’s supervision of its suppliers was not sufficient to prevent deficiencies that would delay FDA approval of Mycapssa; and (iii) as a result of the foregoing, Chiasma’s public statements were materially false and misleading at all relevant times.
On April 15, 2016, the Company announced the receipt of a Complete Response Letter from the FDA, indicating that Chiasma’s New Drug Application for Mycapssa was not ready for approval. Then on April 18, 2016, the Company issued a release clarifying the FDA’s concerns, noting that the FDA recommended Chiasma “conduct a randomized, double-blind and controlled trial...of sufficiently long duration…”
If you suffered a loss in Chiasma you have until August 8, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. To obtain additional information, contact Vincent Wong, Esq. either via email vw@wongesq.com, by telephone at 212.425.1140, or visit http://www.wongesq.com/pslra/chiasma.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT: Vincent Wong, Esq. 39 East Broadway Suite 304 New York, NY 10002 Tel. 212.425.1140 Fax. 866.699.3880 E-Mail: vw@wongesq.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
